Item 8.01 Other Events.
On November 30, 2007, StemCells, Inc. announced that the first patient to receive a transplant of HuCNS-SC cells (purified human neural stem cells) in the Company’s Phase I clinical trial has completed the trial. The patient, who was transplanted in November 2006, has finished the twelve-month period of immunosuppression and follow-up, and undergone the last of the tests and observations required by the trial protocol. A copy of the press release is attached hereto as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| StemCells, Inc. | ||||
| November 30, 2007 | By: |
Kenneth B. Stratton
|
||
| Name: Kenneth B. Stratton | ||||
| Title: General Counsel | ||||
Exhibit Index
| Exhibit No. | Description | |
|
99.1
|
Press Release dated November 30, 2007 |